WPG Advisers’s Charles River Laboratories CRL Stock Holding History

WPG Advisers’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.12K	Hold	27	–	–	﹤0.01%	916
2026 Q1	$4.66K	Sell	27 -3	-10%	-$556	﹤0.01%	898
2025 Q4	$5.98K	Sell	30 -2	-6%	-$363	﹤0.01%	856
2025 Q3	$5.01K	Buy	32 +6	+23%	+$953	﹤0.01%	901
2025 Q2	$3.94K	Buy	26 +17	+189%	+$2.27K	﹤0.01%	952
2025 Q1	$1.35K	Sell	9 -15	-63%	-$2.52K	﹤0.01%	1200
2024 Q4	$4.43K	Buy	+24	New	+$4.62K	﹤0.01%	856

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

WPG Advisers's CRL Position: Q2 2026 in Review

WPG Advisers held its Charles River Laboratories (CRL) position steady in Q2 2026 at 27 shares worth $6.12K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

WPG Advisers first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 260 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

WPG Advisers held 27 shares of Charles River Laboratories worth $6.12K as of Q2 2026.
WPG Advisers left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #916 holding.
WPG Advisers first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
260 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.